• 11/29/2024

Novo Nordisk Upgrades Sales Forecast on Wegovy Demand

Wall Street Journal

Novo Nordisk raised its full-year sales guidance after revenue from its blockbuster Wegovy obesity treatment surged in the second quarter.

https://www.wsj.com/articles/wegovy-maker-novo-nordisk-lifts-sales-guidance-as-weight-loss-drug-demand-continues-to-surge-c5f2b4ed